← All trials
NCT05555199
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 3, 2022
- Primary completion
- Aug 3, 2024
- Completion date
- Oct 10, 2024
- First posted
- Sep 26, 2022
- Last posted
- Dec 12, 2022
- Enrollment
- 60
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Radboud UniversityLead sponsor
- PhilipsCollaborator
- Radboud UniversityOverall official - principal investigator
- Radboud UniversityStudy director
- Johnson and JohnsonCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.